| Financial Year |
March 31 2023 |
| Monetary Funds |
118,339,932.67 |
| Held-for-trading Financial Assets |
615,175,333.33 |
| Notes Receivable |
11,582,502.43 |
| Accounts Receivable |
154,465,523.89 |
| Advances to Suppliers |
7,731,551.45 |
| Other Receivables |
60,510,765.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
28,908,383.48 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,029,349.14 |
| Total Current Assets |
1,006,753,342.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
36,330,624.06 |
| Investment Properties |
41,160,005.21 |
| Fixed Assetes |
86,049,379.29 |
| Under-construction Projects |
624,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
15,828,132.12 |
| R&D expenses |
-- |
| Goodwill |
3,459,002.99 |
| Long-Term Deferred and Prepaid Expenses |
3,447,052.85 |
| Deferred Income Tax Assets |
3,998,577.67 |
| Other Non-Current Assets |
9,431,178.19 |
| Sub-Total of Non-Current Assets |
231,690,069.77 |
| Total Assets |
1,238,443,412.06 |
| Short-Term Loans |
39,950,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
22,184,133.21 |
| Accounts Payable |
50,765,751.87 |
| Accounts Received In Advance |
634,286.66 |
| Employee Compensation Payable |
4,831,008.91 |
| Taxes Payable |
2,079,434.13 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
39,472,961.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,976,593.42 |
| Other Current Liabilities |
12,688,789.58 |
| Sub-Total of Current Liabilities |
177,292,435.33 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
41,899,448.07 |
| Deferred Income Tax Liabilities |
86,250.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
48,721,009.96 |
| Total Liabilities |
226,013,445.29 |
| Paid-In Capital(Or Share Stock) |
579,572,284.00 |
| Capital Surplus |
1,424,745,727.59 |
| Surplus Reserve |
19,602,961.52 |
| LESS:Treasury Stock |
29,997,039.00 |
| Undistributed Profits |
-890,652,072.49 |
| Minority Stockholder's Interest |
9,405,815.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,003,024,151.65 |
| Owner's Equity（Stockholder's Equity） |
1,012,429,966.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,238,443,412.06 |
